BSX vs VRSK · P/E 20, rev $10.65B vs P/E 27, rev $3.07B
Boston Scientific Corp (BSX) versus Verisk Analytics Inc (VRSK) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Verisk Analytics Inc (VRSK) is a consulting services company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported VRSK revenue for 2025-12-31 was $3.07B. Net income was $908.3M. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. VRSK currently screens at market cap $22.97B and trailing P/E 26.7.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. VRSK currently screens at market cap $22.97B and trailing P/E 26.7.
Not investment advice. Open the BSX and VRSK stock pages for the full models.
Not investment advice.